Logo image of ALPAT.PA

PLANT ADVANCED TECHNOLOGIES (ALPAT.PA) Stock Fundamental Analysis

Europe - Euronext Paris - EPA:ALPAT - FR0010785790 - Common Stock

8.38 EUR
-0.04 (-0.48%)
Last: 12/24/2025, 7:00:00 PM
Fundamental Rating

5

Taking everything into account, ALPAT scores 5 out of 10 in our fundamental rating. ALPAT was compared to 81 industry peers in the Biotechnology industry. ALPAT has a medium profitability rating, but doesn't score so well on its financial health evaluation. ALPAT is growing strongly while it is still valued neutral. This is a good combination!


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

In the past year ALPAT was profitable.
In the past year ALPAT had a positive cash flow from operations.
In multiple years ALPAT reported negative net income over the last 5 years.
The reported operating cash flow has been mixed in the past 5 years: ALPAT reported negative operating cash flow in multiple years.
ALPAT.PA Yearly Net Income VS EBIT VS OCF VS FCFALPAT.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1M -1M 2M -2M

1.2 Ratios

Looking at the Return On Assets, with a value of 5.88%, ALPAT is in the better half of the industry, outperforming 78.31% of the companies in the same industry.
ALPAT's Return On Equity of 10.00% is fine compared to the rest of the industry. ALPAT outperforms 78.31% of its industry peers.
The Return On Invested Capital of ALPAT (1.38%) is better than 71.08% of its industry peers.
Industry RankSector Rank
ROA 5.88%
ROE 10%
ROIC 1.38%
ROA(3y)1.25%
ROA(5y)-1.47%
ROE(3y)2.03%
ROE(5y)-3.1%
ROIC(3y)N/A
ROIC(5y)N/A
ALPAT.PA Yearly ROA, ROE, ROICALPAT.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10 -10 -15

1.3 Margins

ALPAT's Profit Margin of 48.78% is amongst the best of the industry. ALPAT outperforms 93.98% of its industry peers.
ALPAT has a Operating Margin of 10.90%. This is in the better half of the industry: ALPAT outperforms 78.31% of its industry peers.
The Gross Margin of ALPAT (116.00%) is better than 100.00% of its industry peers.
ALPAT's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 10.9%
PM (TTM) 48.78%
GM 116%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.17%
GM growth 5Y-4.76%
ALPAT.PA Yearly Profit, Operating, Gross MarginsALPAT.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 -100 -200

3

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so ALPAT is destroying value.
The number of shares outstanding for ALPAT has been increased compared to 1 year ago.
The number of shares outstanding for ALPAT has been increased compared to 5 years ago.
Compared to 1 year ago, ALPAT has an improved debt to assets ratio.
ALPAT.PA Yearly Shares OutstandingALPAT.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200K 400K 600K 800K 1M
ALPAT.PA Yearly Total Debt VS Total AssetsALPAT.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M

2.2 Solvency

Based on the Altman-Z score of 0.54, we must say that ALPAT is in the distress zone and has some risk of bankruptcy.
ALPAT has a Altman-Z score of 0.54. This is comparable to the rest of the industry: ALPAT outperforms 54.22% of its industry peers.
ALPAT has a debt to FCF ratio of 1.64. This is a very positive value and a sign of high solvency as it would only need 1.64 years to pay back of all of its debts.
ALPAT's Debt to FCF ratio of 1.64 is amongst the best of the industry. ALPAT outperforms 81.93% of its industry peers.
ALPAT has a Debt/Equity ratio of 0.15. This is a healthy value indicating a solid balance between debt and equity.
ALPAT has a Debt to Equity ratio of 0.15. This is comparable to the rest of the industry: ALPAT outperforms 55.42% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.15
Debt/FCF 1.64
Altman-Z 0.54
ROIC/WACC0.2
WACC6.78%
ALPAT.PA Yearly LT Debt VS Equity VS FCFALPAT.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2M -2M 4M 6M 8M 10M

2.3 Liquidity

ALPAT has a Current Ratio of 0.58. This is a bad value and indicates that ALPAT is not financially healthy enough and could expect problems in meeting its short term obligations.
ALPAT's Current ratio of 0.58 is on the low side compared to the rest of the industry. ALPAT is outperformed by 83.13% of its industry peers.
A Quick Ratio of 0.31 indicates that ALPAT may have some problems paying its short term obligations.
ALPAT's Quick ratio of 0.31 is on the low side compared to the rest of the industry. ALPAT is outperformed by 92.77% of its industry peers.
Industry RankSector Rank
Current Ratio 0.58
Quick Ratio 0.31
ALPAT.PA Yearly Current Assets VS Current LiabilitesALPAT.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M

7

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 1100.00% over the past year.
ALPAT shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 14.61%.
The Revenue has been growing by 10.44% on average over the past years. This is quite good.
EPS 1Y (TTM)1100%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-27.59%
Revenue 1Y (TTM)14.61%
Revenue growth 3Y-5.79%
Revenue growth 5Y10.44%
Sales Q2Q%-43.46%

3.2 Future

The Earnings Per Share is expected to grow by 68.40% on average over the next years. This is a very strong growth
Based on estimates for the next years, ALPAT will show a very strong growth in Revenue. The Revenue will grow by 31.88% on average per year.
EPS Next Y97.01%
EPS Next 2Y68.4%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year13.04%
Revenue Next 2Y31.88%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
ALPAT.PA Yearly Revenue VS EstimatesALPAT.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 1M 2M 3M 4M
ALPAT.PA Yearly EPS VS EstimatesALPAT.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 0.5 -0.5 -1 -1.5 -2

6

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 9.98, the valuation of ALPAT can be described as reasonable.
Based on the Price/Earnings ratio, ALPAT is valued cheaper than 93.98% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 26.92. ALPAT is valued rather cheaply when compared to this.
ALPAT is expected to report negative earnings next year, which makes the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE 9.98
Fwd PE N/A
ALPAT.PA Price Earnings VS Forward Price EarningsALPAT.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 -100 -200 -300 -400

4.2 Price Multiples

ALPAT's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. ALPAT is cheaper than 75.90% of the companies in the same industry.
ALPAT's Price/Free Cash Flow ratio is rather cheap when compared to the industry. ALPAT is cheaper than 96.39% of the companies in the same industry.
Industry RankSector Rank
P/FCF 4.49
EV/EBITDA 16.03
ALPAT.PA Per share dataALPAT.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8

4.3 Compensation for Growth

ALPAT's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as ALPAT's earnings are expected to grow with 68.40% in the coming years.
PEG (NY)0.1
PEG (5Y)N/A
EPS Next 2Y68.4%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for ALPAT!.
Industry RankSector Rank
Dividend Yield 0%

PLANT ADVANCED TECHNOLOGIES

EPA:ALPAT (12/24/2025, 7:00:00 PM)

8.38

-0.04 (-0.48%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)10-29 2025-10-29
Earnings (Next)03-01 2026-03-01
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners33.62%
Ins Owner ChangeN/A
Market Cap9.39M
Revenue(TTM)1.93M
Net Income(TTM)940.00K
Analysts84.44
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 9.98
Fwd PE N/A
P/S 4.87
P/FCF 4.49
P/OCF 3.75
P/B 1
P/tB 1.63
EV/EBITDA 16.03
EPS(TTM)0.84
EY10.02%
EPS(NY)-0.02
Fwd EYN/A
FCF(TTM)1.87
FCFY22.27%
OCF(TTM)2.23
OCFY26.64%
SpS1.72
BVpS8.39
TBVpS5.14
PEG (NY)0.1
PEG (5Y)N/A
Graham Number12.59
Profitability
Industry RankSector Rank
ROA 5.88%
ROE 10%
ROCE 1.92%
ROIC 1.38%
ROICexc 1.38%
ROICexgc 2.05%
OM 10.9%
PM (TTM) 48.78%
GM 116%
FCFM 108.45%
ROA(3y)1.25%
ROA(5y)-1.47%
ROE(3y)2.03%
ROE(5y)-3.1%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.17%
GM growth 5Y-4.76%
F-Score6
Asset Turnover0.12
Health
Industry RankSector Rank
Debt/Equity 0.15
Debt/FCF 1.64
Debt/EBITDA 1.86
Cap/Depr 73.21%
Cap/Sales 21.27%
Interest Coverage 250
Cash Conversion 324.68%
Profit Quality 222.34%
Current Ratio 0.58
Quick Ratio 0.31
Altman-Z 0.54
F-Score6
WACC6.78%
ROIC/WACC0.2
Cap/Depr(3y)108.69%
Cap/Depr(5y)137.67%
Cap/Sales(3y)44.33%
Cap/Sales(5y)66.12%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)1100%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-27.59%
EPS Next Y97.01%
EPS Next 2Y68.4%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)14.61%
Revenue growth 3Y-5.79%
Revenue growth 5Y10.44%
Sales Q2Q%-43.46%
Revenue Next Year13.04%
Revenue Next 2Y31.88%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y127.63%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year100%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y115.46%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y35.14%
OCF growth 3YN/A
OCF growth 5YN/A

PLANT ADVANCED TECHNOLOGIES / ALPAT.PA FAQ

Can you provide the ChartMill fundamental rating for PLANT ADVANCED TECHNOLOGIES?

ChartMill assigns a fundamental rating of 5 / 10 to ALPAT.PA.


Can you provide the valuation status for PLANT ADVANCED TECHNOLOGIES?

ChartMill assigns a valuation rating of 6 / 10 to PLANT ADVANCED TECHNOLOGIES (ALPAT.PA). This can be considered as Fairly Valued.


Can you provide the profitability details for PLANT ADVANCED TECHNOLOGIES?

PLANT ADVANCED TECHNOLOGIES (ALPAT.PA) has a profitability rating of 5 / 10.


What is the financial health of PLANT ADVANCED TECHNOLOGIES (ALPAT.PA) stock?

The financial health rating of PLANT ADVANCED TECHNOLOGIES (ALPAT.PA) is 3 / 10.